Brind.

The Cutaneous Lymphoma Foundation collaborated with Kyowa Kirin on studies, presenting data at a Congress in Montreal.

1 report, 1 independent Updated Jun 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Cutaneous Lymphoma Foundation Kyowa Kirin

Keep exploring

The entities involved

Cutaneous Lymphoma Foundation
nonprofit organization in Birmingham, United States

Nothing else this week.
Kyowa Kirin
pharmaceutical company
- Jefferies lowered Kyowa Kirin's stock rating on September 1, 2026, for the company headquartered in Tokyo.Thu 05:46

Related events

Kyowa Kirin, Eli Lilly, Kura Oncology, and others are forming a new company to focus on menin inhibitors for disease, involving investment and shared operational teams.Sep 9

Coverage

Newest first; wire copies grouped

Jun 29montrealgazette.com